Literature DB >> 20850053

Alexithymia and emotional awareness in anorexia nervosa: time for a shift in the measurement of the concept?

Thomas Parling1, Modtjaba Mortazavi, Ata Ghaderi.   

Abstract

The present study compared 35 patients with anorexia nervosa (AN) with an age matched control group using the Toronto Alexithymia Scale (TAS-20; a self-report instrument) and the Levels of Emotional Awareness Scale (LEAS; a performance-based instrument). Depression and anxiety have been shown to account for elevated levels of alexithymia in AN, and an elevated level of perfectionism might affect self-reporting in general. The AN-group reported a higher level of alexithymia on the TAS-20 compared to the control group, a difference that disappeared after controlling for depression or anxiety (but not for perfectionism). The findings suggest that the AN-patients believe that they have difficulties in identifying and reporting emotions, but actually perform as well as the control group when confronted with the task of identifying and reporting their emotions according to LEAS. It might be time to rethink the measurement of alexithymia. Maybe, similar to assessment of personality disorders, it should not be assessed when patients are depressed, or it should be assessed through instruments and modalities that are not sensitive to the mood state of the patient.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20850053     DOI: 10.1016/j.eatbeh.2010.04.001

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  26 in total

1.  Momentary emotion identification in female adolescents with and without anorexia nervosa.

Authors:  David R Kolar; Michael Huss; Hanna M Preuss; Ekkehart Jenetzky; Ann F Haynos; Arne Bürger; Florian Hammerle
Journal:  Psychiatry Res       Date:  2017-06-23       Impact factor: 3.222

Review 2.  Alexithymia in Chronic Pain Disorders.

Authors:  Marialaura Di Tella; Lorys Castelli
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

3.  Construct validity of the Levels of Emotional Awareness Scale among women high in eating disorder symptoms: a cross-sectional study.

Authors:  Jillon S Vander Wal; Zachary A Soulliard; Alicia A Kauffman
Journal:  Eat Weight Disord       Date:  2020-06-20       Impact factor: 4.652

4.  Low oxytocin levels are related to alexithymia in anorexia nervosa.

Authors:  Cindy Schmelkin; Franziska Plessow; Jennifer J Thomas; Emily K Gray; Dean A Marengi; Reitumetse Pulumo; Lisseth Silva; Karen K Miller; Nouchine Hadjikhani; Debra L Franko; Kamryn T Eddy; Elizabeth A Lawson
Journal:  Int J Eat Disord       Date:  2017-10-16       Impact factor: 4.861

Review 5.  Dimensions of emotion dysregulation in anorexia nervosa and bulimia nervosa: A conceptual review of the empirical literature.

Authors:  Jason M Lavender; Stephen A Wonderlich; Scott G Engel; Kathryn H Gordon; Walter H Kaye; James E Mitchell
Journal:  Clin Psychol Rev       Date:  2015-06-06

6.  Mindfulness Moderates the Relationship Between Disordered Eating Cognitions and Disordered Eating Behaviors in a Non-Clinical College Sample.

Authors:  Akihiko Masuda; Matthew Price; Robert D Latzman
Journal:  J Psychopathol Behav Assess       Date:  2012-03

7.  Alexithymia, emotional empathy, and self-regulation in anorexia nervosa.

Authors:  Janelle N Beadle; Sergio Paradiso; Alexandria Salerno; Laurie M McCormick
Journal:  Ann Clin Psychiatry       Date:  2013-05       Impact factor: 1.567

8.  Emotion recognition deficits in eating disorders are explained by co-occurring alexithymia.

Authors:  Rebecca Brewer; Richard Cook; Valentina Cardi; Janet Treasure; Geoffrey Bird
Journal:  R Soc Open Sci       Date:  2015-01-21       Impact factor: 2.963

9.  Alexithymia and fibromyalgia: clinical evidence.

Authors:  Marialaura Di Tella; Lorys Castelli
Journal:  Front Psychol       Date:  2013-12-02

10.  Psychosomatic syndromes and anorexia nervosa.

Authors:  Giovanni Abbate-Daga; Nadia Delsedime; Barbara Nicotra; Cristina Giovannone; Enrica Marzola; Federico Amianto; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.